Loading clinical trials...
Loading clinical trials...
To evaluate Safety and Efficacy of Axiostat® hemostatic dressing in terms of time to achieve hemostasis, post application complication and comfort levels of patients.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Axio Biosolutions Pvt. Ltd.
NCT07001332 · High-Risk Percutaneous Coronary Intervention (High-risk PCI)
NCT06909565 · Percutaneous Coronary Intervention, Peripheral Endovascular Intervention
NCT06916520 · Coronary Arterial Disease (CAD), Percutaneous Coronary Intervention (PCI)
NCT07446023 · Percutaneous Coronary Intervention, Intravenous Ultrasound, and more
NCT06788275 · Percutaneous Coronary Intervention (PCI), Acute Myocardial Infarction, and more
Care Institute of Medical Sciences,Nr. Shukan Mall, Off Science City Road,Sola
Ahmedabad, Gujarat
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions